Topics

Insmed's Shares Rocket as Phase II NCFBE Trial Hits Endpoints

19:00 EST 2 Feb 2020 | BioSpace

The company plans to present detailed study results from the WILLOW study at an upcoming medical meeting.

Original Article: Insmed's Shares Rocket as Phase II NCFBE Trial Hits Endpoints

NEXT ARTICLE

More From BioPortfolio on "Insmed's Shares Rocket as Phase II NCFBE Trial Hits Endpoints"

Quick Search